Search miRCancer Database

Search by miRNA name:      Or     And       cancer name:        

Example: mir-145, hsa-mir-21, let-7			 Example: breast cancer, lung

Search result for miRNA = 'hsa-mir-19a' Or cancer = '' Total: 50 relations found.

mirId Family/Cluster Cancer Profile PubMed Article
hsa-mir-19a acute myeloid leukemia up High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
hsa-mir-19a mir-17-92 b-cell lymphoma up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-19a bladder cancer up miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancer.
hsa-mir-19a breast cancer up Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.
hsa-mir-19a breast cancer up MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.
hsa-mir-19a mir-17-92 breast carcinoma up MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
hsa-mir-19a cervical cancer up MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5.
hsa-mir-19a cholangiocarcinoma up miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.
hsa-mir-19a mir-17-92 chronic myelogenous leukemia up miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.
hsa-mir-19a mir-17-92 colorectal cancer up MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
hsa-mir-19a colorectal cancer up Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.
hsa-mir-19a colorectal cancer up Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-? induced epithelial-to-mesenchymal transition in colorectal cancer.
hsa-mir-19a colorectal cancer up miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1.
hsa-mir-19a colorectal cancer down Overexpression of miR-19a inhibits colorectal cancer angiogenesis by suppressing KRAS expression.
hsa-mir-19a mir-17-92 esophageal squamous cell carcinoma up TNF-? is a novel target of miR-19a.
hsa-mir-19a esophageal squamous cell carcinoma up Plasma microRNA-19a as a potential biomarker for esophageal squamous cell carcinoma diagnosis and prognosis.
hsa-mir-19a gastric cancer up MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
hsa-mir-19a gastric cancer up MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
hsa-mir-19a gastric cancer up MicroRNA-19a regulates the proliferation, migration and invasion of human gastric cancer cells by targeting CUL5.
hsa-mir-19a mir-19 gastric cancer up Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.
hsa-mir-19a gastric cancer up MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN.
hsa-mir-19a gastric cancer up miR-19a Promotes Cell Growth and Tumorigenesis through Targeting SOCS1 in Gastric Cancer.
hsa-mir-19a gastric cancer up MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1.
hsa-mir-19a glioma up MicroRNA-19a promotes glioma cell growth by repressing LRIG1.
hsa-mir-19a glioma up miR-19a and miR-19b Overexpression in Gliomas.
hsa-mir-19a glioma up Identification of microRNA signature in different pediatric brain tumors.
hsa-mir-19a mir-17-92 hepatocellular carcinoma up MiR-17-92 cluster promotes hepatocarcinogenesis.
hsa-mir-19a hepatocellular carcinoma up Pterostilbene increases PTEN expression through the targeted downregulation of microRNA-19a in hepatocellular carcinoma.
hsa-mir-19a laryngeal squamous cell carcinoma up MiR-19a is correlated with prognosis and apoptosis of laryngeal squamous cell carcinoma by regulating TIMP-2 expression.
hsa-mir-19a mir-17-92 lung cancer up Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
hsa-mir-19a mir-17-92 lung cancer up MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.
hsa-mir-19a mir-17-92 lung cancer up A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
hsa-mir-19a mir-17-92 mantle cell lymphoma up The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
hsa-mir-19a medulloblastoma up The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
hsa-mir-19a multiple myeloma up MicroRNA-19a functions as an oncogene by regulating PTEN/AKT/pAKT pathway in myeloma.
hsa-mir-19a nasopharyngeal carcinoma up MicroRNA-19a promotes nasopharyngeal carcinoma by targeting transforming growth factor ? receptor 2.
hsa-mir-19a neuroblastoma up MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma.
hsa-mir-19a non-small cell lung cancer up Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer.
hsa-mir-19a mir-19 non-small cell lung cancer up miRNA-19 promotes non-small-cell lung cancer cell proliferation via inhibiting CBX7 expression.
hsa-mir-19a osteosarcoma up MiR-19a regulates the cell growth and apoptosis of osteosarcoma stem cells by targeting PTEN.
hsa-mir-19a mir-17-92 osteosarcoma up Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
hsa-mir-19a mir-19 osteosarcoma up miR-19 promotes osteosarcoma progression by targeting SOCS6.
hsa-mir-19a mir-19 osteosarcoma up MicroRNA-19 contributes to the malignant phenotypes of osteosarcoma in vitro by targeting Pax6.
hsa-mir-19a mir-17-92 osteosarcoma up The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.
hsa-mir-19a ovarian cancer up MiR-19a negatively regulated the expression of PTEN and promoted the growth of ovarian cancer cells.
hsa-mir-19a mir-19 t-cell lymphoblastic lymphoma up Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma.
hsa-mir-19a-3p breast cancer down MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene.
hsa-mir-19a-3p colorectal cancer up A panel of microRNA signature in serum for colorectal cancer diagnosis.
hsa-mir-19a-3p hepatocellular carcinoma up microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma.
hsa-mir-19a-3p multiple myeloma up MicroRNA-19a functions as an oncogene by regulating PTEN/AKT/pAKT pathway in myeloma.